【#Bloomage Biotech Tianjin Company Increases Capital to 1.4 Billion Yuan# 600% Increase】
According to US Stock Research Society, Tianyancha App shows that recently, Bloomage Biotech (Tianjin) Co., Ltd. underwent industrial and commercial changes, with its registered capital increasing from 200 million yuan to 1.4 billion yuan, a 600% increase.
The company was established in August 2018, with Guo Jiajun as its legal representative. Its business scope includes drug production, pharmaceutical excipient production, drug wholesale, drug internet information services, production of special medical purpose formula foods, production of sanitary products and disposable medical supplies, food sales, etc. Shareholder information shows that the company is wholly owned by Bloomage BioTechnology (688363).
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
